AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
October 27 2016 - 8:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that
company management will participate in the following investor
conferences:
- Credit Suisse 2016 Healthcare
ConferenceMonday, November 7, 2016 at 3:00 p.m.
MT (5:00 p.m. ET)Location: Phoenix, AZ
- Jefferies 2016 London Healthcare
ConferenceWednesday, November 16, 2016 at 10:40
a.m. GMT (5:40 a.m. ET)Location: London, U.K.
- Bank of America Merrill Lynch 2016 Leveraged
Finance ConferenceTuesday, November 29, 2016 at
4:10 p.m. ETLocation: Boca Raton, FL
To access the live webcasts, please visit the Investors section
of the company’s website at www.amagpharma.com. A replay of
each event will be archived on the site for 30 days.
About AMAGAMAG is a
biopharmaceutical company focused on developing and delivering
important therapeutics, conducting clinical research in areas of
unmet need and creating education and support programs for the
patients and families we serve. Our products support the health of
patients in the areas of maternal health, anemia management and
cancer supportive care. Through CBR®, we also help families to
preserve newborn stem cells, which are used today in transplant
medicine for certain cancers and blood, immune and metabolic
disorders, and have the potential to play a valuable role in the
ongoing development of regenerative medicine. For additional
company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG
Pharmaceuticals, Inc. and CBR® is a registered trademark
of CBR Systems, Inc.
AMAG Pharmaceuticals Contact:
Christi Waarich
Associate Director, Investor Relations
617-498-7638
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Sep 2023 to Sep 2024